Finegold M - Search Results

1

Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.

Noll M, Battaile KP, Bateman R, Lax TP, Rathbun K, Reifsteck C, Bagby G, Finegold M, Olson S, Grompe M. Noll M, et al. Among authors: finegold m. Exp Hematol. 2002 Jul;30(7):679-88. doi: 10.1016/s0301-472x(02)00838-x. Exp Hematol. 2002. PMID: 12135664 Free article.

2

Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS, Grompe M. Houghtaling S, et al. Among authors: finegold mj. Genes Dev. 2003 Aug 15;17(16):2021-35. doi: 10.1101/gad.1103403. Epub 2003 Jul 31. Genes Dev. 2003. PMID: 12893777 Free PMC article.

3

Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.

Houghtaling S, Granville L, Akkari Y, Torimaru Y, Olson S, Finegold M, Grompe M. Houghtaling S, et al. Among authors: finegold m. Cancer Res. 2005 Jan 1;65(1):85-91. Cancer Res. 2005. PMID: 15665282

4

Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice.

Zhang QS, Eaton L, Snyder ER, Houghtaling S, Mitchell JB, Finegold M, Van Waes C, Grompe M. Zhang QS, et al. Among authors: finegold m. Cancer Res. 2008 Mar 1;68(5):1601-8. doi: 10.1158/0008-5472.CAN-07-5186. Cancer Res. 2008. PMID: 18316625

5

In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.

Montini E, Held PK, Noll M, Morcinek N, Al-Dhalimy M, Finegold M, Yant SR, Kay MA, Grompe M. Montini E, et al. Among authors: finegold m. Mol Ther. 2002 Dec;6(6):759-69. doi: 10.1006/mthe.2002.0812. Mol Ther. 2002. PMID: 12498772 Free article.

6

Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.

Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M. Willenbring H, et al. Among authors: finegold m. Nat Med. 2004 Jul;10(7):744-8. doi: 10.1038/nm1062. Epub 2004 Jun 13. Nat Med. 2004. PMID: 15195088

7

In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.

Manning K, Al-Dhalimy M, Finegold M, Grompe M. Manning K, et al. Among authors: finegold m. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11928-33. doi: 10.1073/pnas.96.21.11928. Proc Natl Acad Sci U S A. 1999. PMID: 10518553 Free PMC article.

8

Ploidy reductions in murine fusion-derived hepatocytes.

Duncan AW, Hickey RD, Paulk NK, Culberson AJ, Olson SB, Finegold MJ, Grompe M. Duncan AW, et al. Among authors: finegold mj. PLoS Genet. 2009 Feb;5(2):e1000385. doi: 10.1371/journal.pgen.1000385. Epub 2009 Feb 20. PLoS Genet. 2009. PMID: 19229314 Free PMC article.

9

Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.

Paulk NK, Wursthorn K, Wang Z, Finegold MJ, Kay MA, Grompe M. Paulk NK, et al. Among authors: finegold mj. Hepatology. 2010 Apr;51(4):1200-8. doi: 10.1002/hep.23481. Hepatology. 2010. PMID: 20162619 Free PMC article.

10

The ploidy conveyor of mature hepatocytes as a source of genetic variation.

Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB, Finegold MJ, Grompe M. Duncan AW, et al. Among authors: finegold mj. Nature. 2010 Oct 7;467(7316):707-10. doi: 10.1038/nature09414. Epub 2010 Sep 22. Nature. 2010. PMID: 20861837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters